Your browser doesn't support javascript.
loading
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s.
Oba, Takaaki; Long, Mark D; Keler, Tibor; Marsh, Henry C; Minderman, Hans; Abrams, Scott I; Liu, Song; Ito, Fumito.
Affiliation
  • Oba T; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Long MD; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Keler T; Celldex Therapeutics, Inc., Hampton, NJ, USA.
  • Marsh HC; Celldex Therapeutics, Inc., Hampton, NJ, USA.
  • Minderman H; Flow & Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Abrams SI; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Liu S; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Ito F; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. fumito.ito@roswellpark.org.
Nat Commun ; 11(1): 5415, 2020 10 27.
Article in En | MEDLINE | ID: mdl-33110069

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Antibodies / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Antibodies / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country: Country of publication: